These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10532418)

  • 1. Expression of apoptosis and its related protein in astrocytic tumors.
    Takekawa Y; Sawada T; Sakurai I
    Brain Tumor Pathol; 1999; 16(1):11-6. PubMed ID: 10532418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
    Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
    J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of apoptotic pathways and c.Jun/JNK expression in malignant gliomas.
    Schiffer D; Ferracini R; Cavalla P
    Anticancer Res; 2001; 21(4A):2531-5. PubMed ID: 11724318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the pro-apoptotic protein ARTS in astrocytic tumors: correlation with malignancy grade and survival rate.
    Gottfried Y; Voldavsky E; Yodko L; Sabo E; Ben-Itzhak O; Larisch S
    Cancer; 2004 Dec; 101(11):2614-21. PubMed ID: 15517578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.
    Ellison DW; Steart PV; Gatter KC; Weller RO
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):352-61. PubMed ID: 7494604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in astrocytic neoplasms.
    Carroll RS; Zhang J; Chauncey BW; Chantziara K; Frosch MP; Black PM
    Acta Neurochir (Wien); 1997; 139(9):845-50. PubMed ID: 9351989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of EphA2 in human astrocytic tumors: correlation with pathologic grade, proliferation and apoptosis.
    Li X; Wang Y; Wang Y; Zhen H; Yang H; Fei Z; Zhang J; Liu W; Wang Y; Zhang X
    Tumour Biol; 2007; 28(3):165-72. PubMed ID: 17519535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
    Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
    J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
    Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
    Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axin induces cell death and reduces cell proliferation in astrocytoma by activating the p53 pathway.
    Zhang LY; Ye J; Zhang F; Li FF; Li H; Gu Y; Liu F; Chen GS; Li Q
    Int J Oncol; 2009 Jul; 35(1):25-32. PubMed ID: 19513548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma.
    Facoetti A; Ranza E; Nano R
    Anticancer Res; 2008; 28(1A):15-9. PubMed ID: 18383819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors.
    Faccion RS; Bernardo PS; de Lopes GPF; Bastos LS; Teixeira CL; de Oliveira JA; Fernandes PV; Dubois LG; Chimelli L; Maia RC
    Cell Oncol (Dordr); 2018 Apr; 41(2):141-157. PubMed ID: 29374392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival.
    Vlodavsky E; Soustiel JF
    J Neurooncol; 2007 Jan; 81(1):1-7. PubMed ID: 16868661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors.
    Khalid H; Shibata S; Kishikawa M; Yasunaga A; Iseki M; Hiura T
    Cancer; 1997 Dec; 80(11):2133-40. PubMed ID: 9392336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors.
    Fujita H; Koji T; Kitagawa N; Tsutsumi K; Abe K; Kaminogo M; Shibata S
    Cell Mol Neurobiol; 2002 Aug; 22(4):393-406. PubMed ID: 12507389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and Fas-ligand expression correlate to the histopathological grade of gastric smooth muscle tumors.
    Liu Y; Chen C; Chen C; Hsieh H; Chang C; Shyu J; Yen C; Harn H
    J Surg Res; 2001 Feb; 95(2):92-8. PubMed ID: 11162031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.